

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.13482367 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.13482367 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.75180266 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.75180266 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51102602 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.47313325 |
| 7 | * glyoxylate metabolic process (GO:0046487) | 5.21479220 |
| 8 | bile acid biosynthetic process (GO:0006699) | 5.10782349 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.08485206 |
| 10 | L-serine metabolic process (GO:0006563) | 5.00084523 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.99606822 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 4.84581566 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.84581566 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.84581566 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66838647 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.65776592 |
| 17 | cysteine metabolic process (GO:0006534) | 4.62358659 |
| 18 | cellular glucuronidation (GO:0052695) | 4.55856355 |
| 19 | epoxygenase P450 pathway (GO:0019373) | 4.55594115 |
| 20 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.53659719 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.50111169 |
| 22 | complement activation, alternative pathway (GO:0006957) | 4.49039934 |
| 23 | kynurenine metabolic process (GO:0070189) | 4.48975860 |
| 24 | urea metabolic process (GO:0019627) | 4.44045685 |
| 25 | urea cycle (GO:0000050) | 4.44045685 |
| 26 | uronic acid metabolic process (GO:0006063) | 4.43597559 |
| 27 | glucuronate metabolic process (GO:0019585) | 4.43597559 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.41291169 |
| 29 | protein carboxylation (GO:0018214) | 4.41291169 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.32035174 |
| 31 | benzene-containing compound metabolic process (GO:0042537) | 4.30690706 |
| 32 | cholesterol biosynthetic process (GO:0006695) | 4.28746241 |
| 33 | bile acid metabolic process (GO:0008206) | 4.28620722 |
| 34 | aldehyde catabolic process (GO:0046185) | 4.26422240 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.14922970 |
| 36 | acetyl-CoA metabolic process (GO:0006084) | 4.14807284 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.13608588 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.12050938 |
| 39 | estrogen biosynthetic process (GO:0006703) | 4.11478202 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 4.10474556 |
| 41 | regulation of protein activation cascade (GO:2000257) | 4.06719333 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.06299913 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.06299913 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.06299913 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 4.06288301 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.05466391 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.04371663 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.01613233 |
| 49 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.01497027 |
| 50 | lysine catabolic process (GO:0006554) | 4.01217119 |
| 51 | lysine metabolic process (GO:0006553) | 4.01217119 |
| 52 | nucleobase catabolic process (GO:0046113) | 3.98063543 |
| 53 | chromatin remodeling at centromere (GO:0031055) | 3.95759877 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 3.95344115 |
| 55 | ethanol oxidation (GO:0006069) | 3.92737130 |
| 56 | serine family amino acid catabolic process (GO:0009071) | 3.92476917 |
| 57 | cholesterol efflux (GO:0033344) | 3.88729103 |
| 58 | establishment of integrated proviral latency (GO:0075713) | 3.88002850 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.87918186 |
| 60 | regulation of fibrinolysis (GO:0051917) | 3.87534441 |
| 61 | regulation of complement activation (GO:0030449) | 3.84223852 |
| 62 | CENP-A containing nucleosome assembly (GO:0034080) | 3.79435590 |
| 63 | very long-chain fatty acid metabolic process (GO:0000038) | 3.78254381 |
| 64 | xenobiotic catabolic process (GO:0042178) | 3.78169308 |
| 65 | coenzyme catabolic process (GO:0009109) | 3.77673744 |
| 66 | ketone body metabolic process (GO:1902224) | 3.74822372 |
| 67 | sterol biosynthetic process (GO:0016126) | 3.74321094 |
| 68 | DNA double-strand break processing (GO:0000729) | 3.74022989 |
| 69 | acylglycerol homeostasis (GO:0055090) | 3.70604030 |
| 70 | triglyceride homeostasis (GO:0070328) | 3.70604030 |
| 71 | drug catabolic process (GO:0042737) | 3.68905715 |
| 72 | response to phenylpropanoid (GO:0080184) | 3.68822490 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.67720691 |
| 74 | response to nitrosative stress (GO:0051409) | 3.65645737 |
| 75 | phospholipid efflux (GO:0033700) | 3.64112520 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 3.61794531 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 3.60467827 |
| 78 | regulation of cholesterol metabolic process (GO:0090181) | 3.59979224 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.59015772 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.57866741 |
| 81 | fatty acid elongation (GO:0030497) | 3.57436850 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.56572992 |
| 83 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.54949345 |
| 84 | drug transmembrane transport (GO:0006855) | 3.53162910 |
| 85 | fatty acid oxidation (GO:0019395) | 3.52055921 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.51994330 |
| 87 | indolalkylamine metabolic process (GO:0006586) | 3.51140510 |
| 88 | phenylpropanoid metabolic process (GO:0009698) | 3.49947034 |
| 89 | negative regulation of sterol transport (GO:0032372) | 3.48119548 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.48119548 |
| 91 | lipid oxidation (GO:0034440) | 3.47630924 |
| 92 | urate metabolic process (GO:0046415) | 3.47527160 |
| 93 | anterior/posterior axis specification, embryo (GO:0008595) | 3.47375419 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.46504715 |
| 95 | amine catabolic process (GO:0009310) | 3.46504715 |
| 96 | cholesterol homeostasis (GO:0042632) | 3.46262338 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.45216698 |
| 98 | thioester metabolic process (GO:0035383) | 3.44716176 |
| 99 | acyl-CoA metabolic process (GO:0006637) | 3.44716176 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.44478878 |
| 101 | monocarboxylic acid catabolic process (GO:0072329) | 3.44295219 |
| 102 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.43827922 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.42312098 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.42214812 |
| 105 | sterol homeostasis (GO:0055092) | 3.41791522 |
| 106 | flavonoid metabolic process (GO:0009812) | 3.39832254 |
| 107 | histone exchange (GO:0043486) | 3.38827418 |
| 108 | organic acid catabolic process (GO:0016054) | 3.37596123 |
| 109 | IMP biosynthetic process (GO:0006188) | 3.34690262 |
| 110 | mitotic metaphase plate congression (GO:0007080) | 3.28211131 |
| 111 | protein localization to kinetochore (GO:0034501) | 3.25688793 |
| 112 | purine nucleobase biosynthetic process (GO:0009113) | 3.20465212 |
| 113 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.19328616 |
| 114 | DNA replication-independent nucleosome organization (GO:0034724) | 3.19328616 |
| 115 | negative regulation of DNA recombination (GO:0045910) | 3.12345924 |
| 116 | DNA replication checkpoint (GO:0000076) | 3.09423380 |
| 117 | pre-miRNA processing (GO:0031054) | 3.09086532 |
| 118 | ribosome assembly (GO:0042255) | 3.07534313 |
| 119 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.05412196 |
| 120 | non-recombinational repair (GO:0000726) | 3.05412196 |
| 121 | proteasome assembly (GO:0043248) | 3.04547868 |
| 122 | metaphase plate congression (GO:0051310) | 3.04150552 |
| 123 | DNA damage response, detection of DNA damage (GO:0042769) | 3.03908942 |
| 124 | spindle checkpoint (GO:0031577) | 2.98405339 |
| 125 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.98172523 |
| 126 | mitotic spindle checkpoint (GO:0071174) | 2.96047142 |
| 127 | glycine metabolic process (GO:0006544) | 2.95692713 |
| 128 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.94276943 |
| 129 | negative regulation of sister chromatid segregation (GO:0033046) | 2.94276943 |
| 130 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.94276943 |
| 131 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.94276943 |
| 132 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.94276943 |
| 133 | establishment of viral latency (GO:0019043) | 2.92445042 |
| 134 | serine family amino acid metabolic process (GO:0009069) | 2.91674566 |
| 135 | DNA ligation (GO:0006266) | 2.90956455 |
| 136 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.89418953 |
| 137 | negative regulation of chromosome segregation (GO:0051985) | 2.86319905 |
| 138 | isoprenoid biosynthetic process (GO:0008299) | 2.85119583 |
| 139 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.85023496 |
| 140 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.85023496 |
| 141 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.84776355 |
| 142 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.84776355 |
| 143 | IMP metabolic process (GO:0046040) | 2.83603082 |
| 144 | regulation of helicase activity (GO:0051095) | 2.83257819 |
| 145 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.79197220 |
| 146 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.79197220 |
| 147 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.77986789 |
| 148 | nucleobase biosynthetic process (GO:0046112) | 2.77395110 |
| 149 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.76749810 |
| 150 | branched-chain amino acid catabolic process (GO:0009083) | 2.75493913 |
| 151 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.74898072 |
| 152 | aspartate family amino acid catabolic process (GO:0009068) | 2.74701918 |
| 153 | protein-lipid complex assembly (GO:0065005) | 2.74384041 |
| 154 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.69355407 |
| 155 | cullin deneddylation (GO:0010388) | 2.68865479 |
| 156 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.64832275 |
| 157 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.64832275 |
| 158 | DNA strand renaturation (GO:0000733) | 2.64751803 |
| 159 | mitotic spindle assembly checkpoint (GO:0007094) | 2.63964049 |
| 160 | tRNA aminoacylation for protein translation (GO:0006418) | 2.61707261 |
| 161 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.60914820 |
| 162 | spindle assembly checkpoint (GO:0071173) | 2.58695587 |
| 163 | regulation of cofactor metabolic process (GO:0051193) | 2.56084336 |
| 164 | regulation of coenzyme metabolic process (GO:0051196) | 2.56084336 |
| 165 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.55700978 |
| 166 | tRNA aminoacylation (GO:0043039) | 2.55260456 |
| 167 | amino acid activation (GO:0043038) | 2.55260456 |
| 168 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.50200570 |
| 169 | negative regulation of ligase activity (GO:0051352) | 2.50200570 |
| 170 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.49530180 |
| 171 | regulation of chromosome segregation (GO:0051983) | 2.49366860 |
| 172 | regulation of centriole replication (GO:0046599) | 2.48831620 |
| 173 | heme transport (GO:0015886) | 2.48033844 |
| 174 | negative regulation of mitosis (GO:0045839) | 2.47662529 |
| 175 | nuclear pore complex assembly (GO:0051292) | 2.45695138 |
| 176 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.45609943 |
| 177 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.45609943 |
| 178 | regulation of sister chromatid segregation (GO:0033045) | 2.45609943 |
| 179 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.45452049 |
| 180 | polyketide metabolic process (GO:0030638) | 2.44686303 |
| 181 | doxorubicin metabolic process (GO:0044598) | 2.44686303 |
| 182 | daunorubicin metabolic process (GO:0044597) | 2.44686303 |
| 183 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.41125302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.51640257 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.76541685 |
| 3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.70825280 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.70043098 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.56480188 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41700598 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.88092412 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.19656596 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.96619202 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.93154423 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.20008072 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.05177331 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.98850214 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.97223594 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.82718931 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.74227085 |
| 17 | * SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.53397888 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.48375958 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.37111032 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.35766998 |
| 21 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.32424386 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.25324009 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22659823 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.21434484 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09158011 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08164717 |
| 27 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.05800196 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97802716 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91712371 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90238849 |
| 31 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.89972314 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87169156 |
| 33 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.85721881 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.83447315 |
| 35 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81887295 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80000805 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79921508 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.79241925 |
| 39 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.75999605 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.74490332 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73589515 |
| 42 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.71706202 |
| 43 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.71706202 |
| 44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.67997738 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67420056 |
| 46 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63880359 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63603473 |
| 48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62352169 |
| 49 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55183508 |
| 50 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.54112688 |
| 51 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51791580 |
| 52 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.51558918 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.51391241 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50797710 |
| 55 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.50740179 |
| 56 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.50740179 |
| 57 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.50740179 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49712197 |
| 59 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.49026472 |
| 60 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47167827 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43920250 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.42947607 |
| 63 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41180116 |
| 64 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41148847 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39344933 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38757404 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38240993 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37920067 |
| 69 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.35573473 |
| 70 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35535478 |
| 71 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35098048 |
| 72 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32903022 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32492143 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31878501 |
| 75 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30483349 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28163853 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.27386613 |
| 78 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26769362 |
| 79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26488470 |
| 80 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25593948 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24702542 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24475994 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.23992487 |
| 84 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.22680024 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22137079 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20458798 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20134236 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19560124 |
| 89 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18907691 |
| 90 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17787952 |
| 91 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16508820 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15290129 |
| 93 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14900402 |
| 94 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14622625 |
| 95 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.13130007 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12567666 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12389706 |
| 98 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12182102 |
| 99 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11257993 |
| 100 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10722914 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08375468 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07912725 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07362121 |
| 104 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07185113 |
| 105 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.06755640 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06621617 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06285815 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05278110 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03300504 |
| 110 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02904327 |
| 111 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02468797 |
| 112 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.01808380 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01645671 |
| 114 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99069314 |
| 115 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.98693395 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98572695 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98495613 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95942833 |
| 119 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95746028 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94908761 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94208540 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93682038 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93475768 |
| 124 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91744258 |
| 125 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91627189 |
| 126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88195985 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88131668 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87679890 |
| 129 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86987302 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86601408 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84487396 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83176366 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82547605 |
| 134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82484509 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81079057 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79934719 |
| 137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79660898 |
| 138 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78902353 |
| 139 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78655260 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78051603 |
| 141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77381103 |
| 142 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76483074 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74717874 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74242904 |
| 145 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73046580 |
| 146 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.72959299 |
| 147 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.71768853 |
| 148 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71435870 |
| 149 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.71425417 |
| 150 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.69626145 |
| 151 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68549016 |
| 152 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.65932698 |
| 153 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.61429152 |
| 154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61175528 |
| 155 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.60528877 |
| 156 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.60025932 |
| 157 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.59735605 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.58967190 |
| 159 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.57358668 |
| 160 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.56446640 |
| 161 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.56252588 |
| 162 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.55587811 |
| 163 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.54421675 |
| 164 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.53781966 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.52548255 |
| 166 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51711288 |
| 167 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.51245204 |
| 168 | P300_19829295_ChIP-Seq_ESCs_Human | 0.50562290 |
| 169 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.50116240 |
| 170 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.49282122 |
| 171 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.49181751 |
| 172 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48568795 |
| 173 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.48435787 |
| 174 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48081977 |
| 175 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.48012219 |
| 176 | RXR_22108803_ChIP-Seq_LS180_Human | 0.47399240 |
| 177 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.46859010 |
| 178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46607925 |
| 179 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.46555254 |
| 180 | VDR_22108803_ChIP-Seq_LS180_Human | 0.45433373 |
| 181 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.45248885 |
| 182 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.45239316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.66428398 |
| 2 | MP0005360_urolithiasis | 6.97088417 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.29127201 |
| 4 | MP0005365_abnormal_bile_salt | 5.18926237 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.75092155 |
| 6 | MP0003195_calcinosis | 4.28257670 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.98726550 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.92377962 |
| 9 | MP0003941_abnormal_skin_development | 3.68010655 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.30731291 |
| 11 | MP0003252_abnormal_bile_duct | 3.14032746 |
| 12 | MP0005332_abnormal_amino_acid | 2.88718298 |
| 13 | MP0009840_abnormal_foam_cell | 2.85821675 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.83750473 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.79284772 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.60490763 |
| 17 | MP0008058_abnormal_DNA_repair | 2.50174453 |
| 18 | MP0005083_abnormal_biliary_tract | 2.46891972 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.43047226 |
| 20 | MP0003122_maternal_imprinting | 2.31641669 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.25317364 |
| 22 | MP0003111_abnormal_nucleus_morphology | 2.24899118 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.12499210 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.06613673 |
| 25 | MP0008932_abnormal_embryonic_tissue | 2.05957674 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.97357917 |
| 27 | MP0003567_abnormal_fetal_cardiomyocyte | 1.95952698 |
| 28 | MP0003121_genomic_imprinting | 1.90207569 |
| 29 | MP0001293_anophthalmia | 1.87417615 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.83581467 |
| 31 | MP0003186_abnormal_redox_activity | 1.83264063 |
| 32 | MP0009672_abnormal_birth_weight | 1.81177166 |
| 33 | MP0003119_abnormal_digestive_system | 1.77706524 |
| 34 | MP0000609_abnormal_liver_physiology | 1.76944657 |
| 35 | MP0001529_abnormal_vocalization | 1.75091077 |
| 36 | MP0003136_yellow_coat_color | 1.72079899 |
| 37 | MP0002938_white_spotting | 1.71852599 |
| 38 | MP0003077_abnormal_cell_cycle | 1.71458422 |
| 39 | MP0003690_abnormal_glial_cell | 1.66871351 |
| 40 | MP0008057_abnormal_DNA_replication | 1.63570094 |
| 41 | MP0003011_delayed_dark_adaptation | 1.61667834 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60689128 |
| 43 | MP0003937_abnormal_limbs/digits/tail_de | 1.60329372 |
| 44 | MP0008007_abnormal_cellular_replicative | 1.59201939 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.58201141 |
| 46 | MP0001730_embryonic_growth_arrest | 1.55011727 |
| 47 | MP0004133_heterotaxia | 1.53023715 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.49633844 |
| 49 | MP0003123_paternal_imprinting | 1.49427193 |
| 50 | MP0006054_spinal_hemorrhage | 1.48915940 |
| 51 | MP0005499_abnormal_olfactory_system | 1.48676571 |
| 52 | MP0005394_taste/olfaction_phenotype | 1.48676571 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.47303796 |
| 54 | MP0010030_abnormal_orbit_morphology | 1.46361116 |
| 55 | MP0006292_abnormal_olfactory_placode | 1.42630694 |
| 56 | MP0002084_abnormal_developmental_patter | 1.36221880 |
| 57 | MP0002102_abnormal_ear_morphology | 1.35529481 |
| 58 | MP0003868_abnormal_feces_composition | 1.32493213 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.32216281 |
| 60 | MP0002233_abnormal_nose_morphology | 1.30649679 |
| 61 | MP0000604_amyloidosis | 1.29870951 |
| 62 | MP0009053_abnormal_anal_canal | 1.29296140 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.26782724 |
| 64 | MP0001672_abnormal_embryogenesis/_devel | 1.26174746 |
| 65 | MP0005380_embryogenesis_phenotype | 1.26174746 |
| 66 | MP0002697_abnormal_eye_size | 1.26120546 |
| 67 | MP0005451_abnormal_body_composition | 1.25685128 |
| 68 | MP0005647_abnormal_sex_gland | 1.25383313 |
| 69 | MP0001286_abnormal_eye_development | 1.24359386 |
| 70 | MP0005408_hypopigmentation | 1.23073861 |
| 71 | MP0001984_abnormal_olfaction | 1.21754115 |
| 72 | MP0003315_abnormal_perineum_morphology | 1.20226439 |
| 73 | MP0009703_decreased_birth_body | 1.20130247 |
| 74 | MP0001697_abnormal_embryo_size | 1.16000834 |
| 75 | MP0001764_abnormal_homeostasis | 1.15948074 |
| 76 | MP0002085_abnormal_embryonic_tissue | 1.15650657 |
| 77 | MP0001661_extended_life_span | 1.11884587 |
| 78 | MP0002111_abnormal_tail_morphology | 1.07928311 |
| 79 | MP0009697_abnormal_copulation | 1.06221753 |
| 80 | MP0003984_embryonic_growth_retardation | 1.04469214 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 1.04004870 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 1.03488854 |
| 83 | MP0000516_abnormal_urinary_system | 1.03173934 |
| 84 | MP0005367_renal/urinary_system_phenotyp | 1.03173934 |
| 85 | MP0004130_abnormal_muscle_cell | 1.02152470 |
| 86 | MP0009764_decreased_sensitivity_to | 1.01918136 |
| 87 | MP0004272_abnormal_basement_membrane | 1.00534083 |
| 88 | MP0002876_abnormal_thyroid_physiology | 1.00145079 |
| 89 | MP0000598_abnormal_liver_morphology | 0.98453006 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.97070512 |
| 91 | MP0000566_synostosis | 0.96596383 |
| 92 | MP0003329_amyloid_beta_deposits | 0.94625527 |
| 93 | MP0001756_abnormal_urination | 0.93989742 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.93901736 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.93841038 |
| 96 | MP0005670_abnormal_white_adipose | 0.92923423 |
| 97 | MP0001188_hyperpigmentation | 0.92902033 |
| 98 | MP0002254_reproductive_system_inflammat | 0.92332296 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.92297999 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.91642493 |
| 101 | MP0002751_abnormal_autonomic_nervous | 0.91227170 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.91042747 |
| 103 | MP0002080_prenatal_lethality | 0.90565676 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 0.90423296 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.90293114 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.89859849 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.88815154 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.88255250 |
| 109 | MP0005334_abnormal_fat_pad | 0.87278118 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.86357109 |
| 111 | MP0003786_premature_aging | 0.86309635 |
| 112 | MP0002168_other_aberrant_phenotype | 0.84555737 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.84522704 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.84229070 |
| 115 | MP0000350_abnormal_cell_proliferation | 0.83299856 |
| 116 | MP0002092_abnormal_eye_morphology | 0.80510329 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.80284847 |
| 118 | MP0009763_increased_sensitivity_to | 0.79912120 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.79308883 |
| 120 | MP0003755_abnormal_palate_morphology | 0.79177465 |
| 121 | MP0002736_abnormal_nociception_after | 0.78152944 |
| 122 | MP0005391_vision/eye_phenotype | 0.76729453 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.76719852 |
| 124 | MP0004883_abnormal_blood_vessel | 0.76345912 |
| 125 | MP0005395_other_phenotype | 0.74991361 |
| 126 | MP0005535_abnormal_body_temperature | 0.73412573 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.72995326 |
| 128 | MP0005253_abnormal_eye_physiology | 0.72828031 |
| 129 | MP0001915_intracranial_hemorrhage | 0.72775756 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.71554371 |
| 131 | MP0001929_abnormal_gametogenesis | 0.71510369 |
| 132 | MP0002971_abnormal_brown_adipose | 0.71452662 |
| 133 | MP0005551_abnormal_eye_electrophysiolog | 0.71384842 |
| 134 | MP0010307_abnormal_tumor_latency | 0.70926947 |
| 135 | MP0000920_abnormal_myelination | 0.70587940 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.70101237 |
| 137 | MP0003861_abnormal_nervous_system | 0.70063381 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.69082010 |
| 139 | MP0008469_abnormal_protein_level | 0.67216776 |
| 140 | MP0005164_abnormal_response_to | 0.66021749 |
| 141 | MP0004043_abnormal_pH_regulation | 0.63402426 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.59925057 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.59025236 |
| 144 | MP0006035_abnormal_mitochondrial_morpho | 0.56055354 |
| 145 | MP0005197_abnormal_uvea_morphology | 0.56001353 |
| 146 | MP0004185_abnormal_adipocyte_glucose | 0.55925837 |
| 147 | MP0005220_abnormal_exocrine_pancreas | 0.55909594 |
| 148 | MP0003724_increased_susceptibility_to | 0.51793863 |
| 149 | MP0000647_abnormal_sebaceous_gland | 0.51705538 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.51188156 |
| 151 | MP0005448_abnormal_energy_balance | 0.49966411 |
| 152 | MP0005266_abnormal_metabolism | 0.49708776 |
| 153 | MP0002090_abnormal_vision | 0.49581760 |
| 154 | MP0001177_atelectasis | 0.48128976 |
| 155 | MP0002282_abnormal_trachea_morphology | 0.47125326 |
| 156 | MP0006036_abnormal_mitochondrial_physio | 0.44473835 |
| 157 | MP0003953_abnormal_hormone_level | 0.43562397 |
| 158 | MP0005275_abnormal_skin_tensile | 0.42921900 |
| 159 | MP0002796_impaired_skin_barrier | 0.42173309 |
| 160 | MP0001881_abnormal_mammary_gland | 0.40486933 |
| 161 | MP0009115_abnormal_fat_cell | 0.40405642 |
| 162 | MP0001542_abnormal_bone_strength | 0.39289102 |
| 163 | MP0003718_maternal_effect | 0.39081673 |
| 164 | MP0003959_abnormal_lean_body | 0.39011825 |
| 165 | MP0001324_abnormal_eye_pigmentation | 0.35283027 |
| 166 | MP0000462_abnormal_digestive_system | 0.35264160 |
| 167 | MP0000537_abnormal_urethra_morphology | 0.35258424 |
| 168 | MP0000778_abnormal_nervous_system | 0.34444371 |
| 169 | MP0003436_decreased_susceptibility_to | 0.33557183 |
| 170 | MP0003075_altered_response_to | 0.32505042 |
| 171 | MP0002135_abnormal_kidney_morphology | 0.32417943 |
| 172 | MP0002896_abnormal_bone_mineralization | 0.32363639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.02322087 |
| 2 | Xanthomatosis (HP:0000991) | 5.98075523 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.80112958 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.75464659 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.39363540 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.13331687 |
| 7 | Epidermoid cyst (HP:0200040) | 5.09396738 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.00952904 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.59190161 |
| 10 | Complement deficiency (HP:0004431) | 4.57575838 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.48155618 |
| 12 | Hyperglycinuria (HP:0003108) | 4.41607034 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.32988427 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.32988427 |
| 15 | Abnormality of the labia minora (HP:0012880) | 4.21855796 |
| 16 | Hyperammonemia (HP:0001987) | 4.14656474 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.01994469 |
| 18 | Hyperglycinemia (HP:0002154) | 3.94695647 |
| 19 | Ketosis (HP:0001946) | 3.86664367 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81487144 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.80583183 |
| 22 | Fat malabsorption (HP:0002630) | 3.72095165 |
| 23 | Joint hemorrhage (HP:0005261) | 3.69544909 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.67880331 |
| 25 | Cortical dysplasia (HP:0002539) | 3.65215617 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.49625060 |
| 27 | Colon cancer (HP:0003003) | 3.49203702 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45998744 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39273894 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.39003584 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.37619259 |
| 32 | Abnormality of complement system (HP:0005339) | 3.37394553 |
| 33 | Abnormal lung lobation (HP:0002101) | 3.21240430 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.17519658 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.13550581 |
| 36 | Skin nodule (HP:0200036) | 3.10450250 |
| 37 | Ketoacidosis (HP:0001993) | 3.09913686 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.09784819 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.05315942 |
| 40 | Ependymoma (HP:0002888) | 3.02824536 |
| 41 | Abnormality of glycolysis (HP:0004366) | 2.93291982 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.93291982 |
| 43 | Steatorrhea (HP:0002570) | 2.92931327 |
| 44 | Hydroxyprolinuria (HP:0003080) | 2.88698939 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.88698939 |
| 46 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.82736298 |
| 47 | Hepatoblastoma (HP:0002884) | 2.81257256 |
| 48 | Bifid tongue (HP:0010297) | 2.80330144 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.74928016 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.74503357 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.72839728 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.71352704 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.70308330 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.69531166 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.65421214 |
| 56 | Agnosia (HP:0010524) | 2.62219664 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62108345 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.62108345 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.62101394 |
| 60 | Myocardial infarction (HP:0001658) | 2.61977870 |
| 61 | Meckel diverticulum (HP:0002245) | 2.60806821 |
| 62 | Vascular calcification (HP:0004934) | 2.60286794 |
| 63 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.58737467 |
| 64 | Lethargy (HP:0001254) | 2.58547160 |
| 65 | Embryonal renal neoplasm (HP:0011794) | 2.57022268 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.56917788 |
| 67 | Rhabdomyosarcoma (HP:0002859) | 2.55093656 |
| 68 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.54285915 |
| 69 | Medulloblastoma (HP:0002885) | 2.50770393 |
| 70 | Nausea (HP:0002018) | 2.50369002 |
| 71 | Hypophosphatemic rickets (HP:0004912) | 2.47122787 |
| 72 | Cerebral edema (HP:0002181) | 2.46678269 |
| 73 | Septo-optic dysplasia (HP:0100842) | 2.46210649 |
| 74 | Glomerulonephritis (HP:0000099) | 2.45848110 |
| 75 | Abnormality of the ileum (HP:0001549) | 2.45773820 |
| 76 | Glycosuria (HP:0003076) | 2.45693317 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.45693317 |
| 78 | Metabolic acidosis (HP:0001942) | 2.43500259 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42922036 |
| 80 | Gout (HP:0001997) | 2.42136865 |
| 81 | Methylmalonic acidemia (HP:0002912) | 2.41914050 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.40402138 |
| 83 | Hypoplastic pelvis (HP:0008839) | 2.40157971 |
| 84 | Abnormality of chromosome stability (HP:0003220) | 2.35973759 |
| 85 | Irritability (HP:0000737) | 2.34468675 |
| 86 | Vomiting (HP:0002013) | 2.31110026 |
| 87 | Hemorrhage of the eye (HP:0011885) | 2.30865089 |
| 88 | Intestinal atresia (HP:0011100) | 2.30225576 |
| 89 | Rickets (HP:0002748) | 2.25592915 |
| 90 | Supernumerary spleens (HP:0009799) | 2.25501887 |
| 91 | Enlarged kidneys (HP:0000105) | 2.23875440 |
| 92 | Gonadotropin excess (HP:0000837) | 2.22819579 |
| 93 | Myelomeningocele (HP:0002475) | 2.22812748 |
| 94 | Spastic diplegia (HP:0001264) | 2.22142758 |
| 95 | Glioma (HP:0009733) | 2.21997963 |
| 96 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.18943136 |
| 97 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.17410790 |
| 98 | Abnormality of alanine metabolism (HP:0010916) | 2.17410790 |
| 99 | Hyperalaninemia (HP:0003348) | 2.17410790 |
| 100 | Hypoplastic female external genitalia (HP:0012815) | 2.10381910 |
| 101 | Brushfield spots (HP:0001088) | 2.08964786 |
| 102 | Alkalosis (HP:0001948) | 2.08499233 |
| 103 | Chromsome breakage (HP:0040012) | 2.08199252 |
| 104 | Abnormality of the duodenum (HP:0002246) | 2.07204432 |
| 105 | Malnutrition (HP:0004395) | 2.06754967 |
| 106 | Astrocytoma (HP:0009592) | 2.05168623 |
| 107 | Abnormality of the astrocytes (HP:0100707) | 2.05168623 |
| 108 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.04642065 |
| 109 | Labial hypoplasia (HP:0000066) | 2.04310012 |
| 110 | Spontaneous abortion (HP:0005268) | 2.03397609 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 2.02313383 |
| 112 | Mitral stenosis (HP:0001718) | 2.02238901 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01315375 |
| 114 | Neurofibrillary tangles (HP:0002185) | 2.00445588 |
| 115 | Birth length less than 3rd percentile (HP:0003561) | 1.99695268 |
| 116 | Pancreatitis (HP:0001733) | 1.98606299 |
| 117 | Amyloidosis (HP:0011034) | 1.98228998 |
| 118 | Opisthotonus (HP:0002179) | 1.96964663 |
| 119 | Anal stenosis (HP:0002025) | 1.94351660 |
| 120 | Acute encephalopathy (HP:0006846) | 1.92842874 |
| 121 | Axonal loss (HP:0003447) | 1.92713015 |
| 122 | Abnormality of the preputium (HP:0100587) | 1.90818415 |
| 123 | Stenosis of the external auditory canal (HP:0000402) | 1.90605490 |
| 124 | Abnormal hair whorl (HP:0010721) | 1.90058776 |
| 125 | Methylmalonic aciduria (HP:0012120) | 1.89019748 |
| 126 | Epiphyseal stippling (HP:0010655) | 1.88617799 |
| 127 | Renal hypoplasia (HP:0000089) | 1.87539021 |
| 128 | Vaginal fistula (HP:0004320) | 1.87371973 |
| 129 | Increased purine levels (HP:0004368) | 1.86948532 |
| 130 | Hyperuricemia (HP:0002149) | 1.86948532 |
| 131 | Neonatal onset (HP:0003623) | 1.86767777 |
| 132 | Abnormality of the clitoris (HP:0000056) | 1.85106669 |
| 133 | Absent radius (HP:0003974) | 1.84847435 |
| 134 | Increased nuchal translucency (HP:0010880) | 1.84673575 |
| 135 | Small intestinal stenosis (HP:0012848) | 1.84499808 |
| 136 | Duodenal stenosis (HP:0100867) | 1.84499808 |
| 137 | Volvulus (HP:0002580) | 1.84126625 |
| 138 | Clitoromegaly (HP:0000057) | 1.83689885 |
| 139 | Hypochromic microcytic anemia (HP:0004840) | 1.82945163 |
| 140 | Acanthocytosis (HP:0001927) | 1.82085803 |
| 141 | Hypoglycemic seizures (HP:0002173) | 1.82026070 |
| 142 | Scrotal hypoplasia (HP:0000046) | 1.81758762 |
| 143 | Abnormality of the anterior horn cell (HP:0006802) | 1.80196157 |
| 144 | Degeneration of anterior horn cells (HP:0002398) | 1.80196157 |
| 145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79809151 |
| 146 | Abnormal gallbladder morphology (HP:0012437) | 1.79170978 |
| 147 | Nephritis (HP:0000123) | 1.78603073 |
| 148 | Elevated alkaline phosphatase (HP:0003155) | 1.78473899 |
| 149 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.78428261 |
| 150 | Megaloblastic anemia (HP:0001889) | 1.77100338 |
| 151 | Renal cortical cysts (HP:0000803) | 1.76594891 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76026686 |
| 153 | Absent forearm bone (HP:0003953) | 1.75105041 |
| 154 | Aplasia involving forearm bones (HP:0009822) | 1.75105041 |
| 155 | Spastic paraparesis (HP:0002313) | 1.74120338 |
| 156 | Choanal stenosis (HP:0000452) | 1.73831011 |
| 157 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.73760097 |
| 158 | * Abnormal cartilage morphology (HP:0002763) | 1.73283075 |
| 159 | Esophageal varix (HP:0002040) | 1.72567466 |
| 160 | Symptomatic seizures (HP:0011145) | 1.71771602 |
| 161 | Biliary tract neoplasm (HP:0100574) | 1.70743863 |
| 162 | Back pain (HP:0003418) | 1.70553716 |
| 163 | Bifid scrotum (HP:0000048) | 1.69163389 |
| 164 | Abnormal biliary tract physiology (HP:0012439) | 1.69096103 |
| 165 | Bile duct proliferation (HP:0001408) | 1.69096103 |
| 166 | Hemivertebrae (HP:0002937) | 1.68782828 |
| 167 | Abnormality of the labia (HP:0000058) | 1.67927788 |
| 168 | Neoplasm of the colon (HP:0100273) | 1.67038766 |
| 169 | Rectal fistula (HP:0100590) | 1.66861809 |
| 170 | Rectovaginal fistula (HP:0000143) | 1.66861809 |
| 171 | Anophthalmia (HP:0000528) | 1.65614349 |
| 172 | Decreased muscle mass (HP:0003199) | 1.65521611 |
| 173 | Postnatal microcephaly (HP:0005484) | 1.65162111 |
| 174 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.65084941 |
| 175 | Gastrointestinal carcinoma (HP:0002672) | 1.65084941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.48874362 |
| 2 | TRIM28 | 3.52898423 |
| 3 | TSSK6 | 3.41171200 |
| 4 | TTK | 3.10076152 |
| 5 | BUB1 | 3.06367552 |
| 6 | MARK1 | 3.02719286 |
| 7 | EPHB1 | 2.93263866 |
| 8 | SIK1 | 2.81861056 |
| 9 | MKNK2 | 2.74242398 |
| 10 | NEK1 | 2.63112801 |
| 11 | STK39 | 2.61993517 |
| 12 | ACVR1B | 2.59491076 |
| 13 | SRPK1 | 2.48288701 |
| 14 | MST1R | 2.47797205 |
| 15 | PLK3 | 2.44581284 |
| 16 | MKNK1 | 2.41422914 |
| 17 | ERBB4 | 2.33381280 |
| 18 | FGFR4 | 2.30583534 |
| 19 | DYRK2 | 2.29783513 |
| 20 | PBK | 2.20095250 |
| 21 | CDC7 | 2.16769306 |
| 22 | BCR | 2.14461272 |
| 23 | EIF2AK3 | 2.06391464 |
| 24 | WNK4 | 2.05907327 |
| 25 | PLK4 | 2.05808572 |
| 26 | OXSR1 | 2.05291615 |
| 27 | ERN1 | 1.98285931 |
| 28 | LIMK1 | 1.98215043 |
| 29 | FRK | 1.97614809 |
| 30 | ZAK | 1.83826924 |
| 31 | WEE1 | 1.81268645 |
| 32 | BRSK2 | 1.80312250 |
| 33 | ERBB3 | 1.79602712 |
| 34 | EPHB2 | 1.77791311 |
| 35 | EIF2AK1 | 1.74601104 |
| 36 | ABL2 | 1.74219925 |
| 37 | INSRR | 1.68077885 |
| 38 | MET | 1.65562514 |
| 39 | CASK | 1.62420587 |
| 40 | FGFR2 | 1.60078985 |
| 41 | WNK3 | 1.56671032 |
| 42 | PKN1 | 1.48764776 |
| 43 | PIK3CG | 1.47319971 |
| 44 | TAF1 | 1.41100608 |
| 45 | PLK1 | 1.40279084 |
| 46 | LATS1 | 1.39750044 |
| 47 | NEK9 | 1.35174184 |
| 48 | IRAK2 | 1.31767181 |
| 49 | VRK2 | 1.31244112 |
| 50 | PKN2 | 1.28642095 |
| 51 | MAP3K14 | 1.26424167 |
| 52 | MAPK13 | 1.26391339 |
| 53 | SGK494 | 1.22924838 |
| 54 | SGK223 | 1.22924838 |
| 55 | CSNK1G3 | 1.22306573 |
| 56 | STK16 | 1.22005906 |
| 57 | GSK3A | 1.18970764 |
| 58 | CSNK1G1 | 1.13610569 |
| 59 | PAK3 | 1.11605730 |
| 60 | CSNK1A1L | 1.10881499 |
| 61 | PLK2 | 1.09741536 |
| 62 | VRK1 | 1.09259833 |
| 63 | PNCK | 1.07383787 |
| 64 | IRAK4 | 1.06661167 |
| 65 | TGFBR1 | 1.02122606 |
| 66 | NUAK1 | 0.99029121 |
| 67 | TNIK | 0.98098331 |
| 68 | PRKCZ | 0.97596678 |
| 69 | TESK1 | 0.97336812 |
| 70 | CAMK1D | 0.97107872 |
| 71 | MST4 | 0.95702727 |
| 72 | EPHA3 | 0.94886572 |
| 73 | PDK2 | 0.94602200 |
| 74 | PIK3CA | 0.91802233 |
| 75 | DYRK1B | 0.89196479 |
| 76 | ERBB2 | 0.88506600 |
| 77 | CSNK1G2 | 0.88308409 |
| 78 | BRSK1 | 0.84618824 |
| 79 | MAP4K2 | 0.82353797 |
| 80 | PTK6 | 0.81777458 |
| 81 | MAP3K4 | 0.81477583 |
| 82 | ATR | 0.76254294 |
| 83 | FLT3 | 0.75345079 |
| 84 | ALK | 0.74678126 |
| 85 | MAP2K1 | 0.74315444 |
| 86 | PAK4 | 0.72869907 |
| 87 | CDK6 | 0.70930678 |
| 88 | LMTK2 | 0.70844304 |
| 89 | ROCK1 | 0.70715953 |
| 90 | STK38L | 0.70174888 |
| 91 | TYRO3 | 0.68825936 |
| 92 | ATM | 0.68019348 |
| 93 | GRK1 | 0.67758333 |
| 94 | IRAK1 | 0.66487685 |
| 95 | STK3 | 0.64524703 |
| 96 | TAOK3 | 0.62949665 |
| 97 | BLK | 0.62630975 |
| 98 | PASK | 0.62227814 |
| 99 | PRKCE | 0.62031343 |
| 100 | NEK2 | 0.61936654 |
| 101 | YES1 | 0.61632260 |
| 102 | MYLK | 0.61432103 |
| 103 | MAPK4 | 0.61395793 |
| 104 | CHEK2 | 0.61374037 |
| 105 | CSNK1E | 0.61177666 |
| 106 | EIF2AK2 | 0.60469384 |
| 107 | DYRK3 | 0.58975131 |
| 108 | JAK2 | 0.58954378 |
| 109 | AURKB | 0.58310308 |
| 110 | TRIB3 | 0.58219309 |
| 111 | PRKACG | 0.57874605 |
| 112 | MAP3K2 | 0.57618272 |
| 113 | SIK3 | 0.57610083 |
| 114 | NLK | 0.56246105 |
| 115 | MAP2K4 | 0.55120845 |
| 116 | TYK2 | 0.53787073 |
| 117 | LATS2 | 0.53383226 |
| 118 | NTRK1 | 0.52770967 |
| 119 | PRKAA2 | 0.52388316 |
| 120 | MINK1 | 0.51645349 |
| 121 | PTK2 | 0.51426387 |
| 122 | IGF1R | 0.51117787 |
| 123 | BMPR1B | 0.50573282 |
| 124 | NME1 | 0.50497095 |
| 125 | PRKCG | 0.49805617 |
| 126 | PRKAA1 | 0.49282808 |
| 127 | STK4 | 0.48730657 |
| 128 | CHEK1 | 0.48621827 |
| 129 | TBK1 | 0.48553344 |
| 130 | CDK7 | 0.48316126 |
| 131 | EPHA4 | 0.48165528 |
| 132 | FER | 0.47776586 |
| 133 | MAPK11 | 0.46504391 |
| 134 | DAPK2 | 0.46045023 |
| 135 | DDR2 | 0.45177844 |
| 136 | MAPK12 | 0.44317169 |
| 137 | CSNK2A1 | 0.44211032 |
| 138 | SGK2 | 0.44091728 |
| 139 | PRKCQ | 0.43559394 |
| 140 | AKT3 | 0.43127888 |
| 141 | ICK | 0.42720951 |
| 142 | FGFR1 | 0.42259705 |
| 143 | PHKG1 | 0.41512455 |
| 144 | PHKG2 | 0.41512455 |
| 145 | CAMK1G | 0.40083482 |
| 146 | RIPK1 | 0.39301620 |
| 147 | CSNK2A2 | 0.38827179 |
| 148 | CAMK2G | 0.38586351 |
| 149 | CDK1 | 0.38546415 |
| 150 | PRKDC | 0.37870514 |
| 151 | PRKCD | 0.37072924 |
| 152 | UHMK1 | 0.36322218 |
| 153 | MAP2K7 | 0.36145041 |
| 154 | CSK | 0.35842980 |
| 155 | RET | 0.35833005 |
| 156 | MAP3K8 | 0.34438788 |
| 157 | RPS6KA4 | 0.30931594 |
| 158 | PRKD3 | 0.30298887 |
| 159 | CSNK1A1 | 0.29465289 |
| 160 | TIE1 | 0.28141237 |
| 161 | CDK18 | 0.27955170 |
| 162 | CDK2 | 0.27042258 |
| 163 | PINK1 | 0.26954069 |
| 164 | STK10 | 0.25834345 |
| 165 | PRKACB | 0.25599849 |
| 166 | MAP3K12 | 0.25065581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.52077192 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21298943 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.12424104 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.92181182 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.91434911 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76161350 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.68046723 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67941362 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.57007286 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46044066 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45427910 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43922886 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.39778057 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32123932 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29750677 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29384420 |
| 17 | * Peroxisome_Homo sapiens_hsa04146 | 2.23572179 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15045361 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11728684 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10990744 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06276294 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.04642688 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.03623817 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.03087192 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01444771 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 2.00457923 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.00045747 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.98347846 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96954950 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.93106270 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77471125 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.75532164 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68794676 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61223307 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58609481 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54076740 |
| 37 | DNA replication_Homo sapiens_hsa03030 | 1.52463466 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50595072 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48506690 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47163134 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45404429 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43168695 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35026385 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32344061 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.27531258 |
| 46 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24407790 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21350160 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.20114133 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.15649573 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15564829 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13667383 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.13378919 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09238286 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 1.09219064 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07641508 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.07342153 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 1.07213010 |
| 58 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.06697265 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06004521 |
| 60 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.04464608 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00190288 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.00177099 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 0.98438310 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97261427 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.96410077 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90626470 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88608658 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82671712 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79576777 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.77905487 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75526493 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70337402 |
| 73 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70241809 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64614926 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63372823 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62624835 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62157273 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.60491992 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59387154 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57873928 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54994036 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53132260 |
| 83 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51733519 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50979800 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50501022 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50288942 |
| 87 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49515509 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.48046020 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44994938 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42498358 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41975320 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41723464 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36770116 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36305941 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35687789 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.34898640 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29762760 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.29547163 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29343121 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26902595 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24647314 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24165849 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20741142 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19209451 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17019085 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.15305238 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14948900 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.14871030 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.14433410 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14016848 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13934441 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.13086843 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.09912654 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08718833 |
| 115 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.05233618 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | -0.1489124 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.1309953 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1296019 |
| 119 | Proteasome_Homo sapiens_hsa03050 | -0.1177370 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1174575 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1121370 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1119030 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | -0.1085025 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0952444 |
| 125 | Pertussis_Homo sapiens_hsa05133 | -0.0885334 |
| 126 | Axon guidance_Homo sapiens_hsa04360 | -0.0591442 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0512986 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0510707 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0133957 |

